CORRELATION OF THE INSULIN RECEPTOR EXPRESSION AND THE RESISTANCE TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

被引:0
|
作者
Takahashi, Masayuki
Daizumoto, Kei
Fukuhara, Yayoi
Ozaki, Keisuke
Tsuda, Megumi
Kusuhara, Yoshito
Mori, Hidehisa
Fukawa, Tomoya
Yamamoto, Yasuyo
Yamaguchi, Kunihisa
Fukumori, Tomoharu
Kanayama, Hiroomi
机构
来源
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP72-06
引用
收藏
页码:E954 / E954
页数:1
相关论文
共 50 条
  • [31] The Relationship of Vascular Endothelial Growth Factor and Coagulation Factor (Fibrin and Fibrinogen) Expression in Clear Cell Renal Cell Carcinoma
    Verheul, Henk M. W.
    van Erp, Karen
    Homs, Marjolein Y. V.
    Yoon, G. S.
    van Der Groep, Petra
    Rogers, Craig
    Hansel, Donna E.
    Netto, George J.
    Pili, Roberto
    UROLOGY, 2010, 75 (03) : 608 - 614
  • [32] Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
    Gustafsson, Anna
    Bostrom, Anna-Karin
    Ljungberg, Borje
    Axelson, Hakan
    Dahlback, Bjorn
    PLOS ONE, 2009, 4 (10):
  • [33] QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    P Ghatalia
    Y Je
    M D Kaymakcalan
    G Sonpavde
    T K Choueiri
    British Journal of Cancer, 2015, 112 : 296 - 305
  • [34] QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Ghatalia, P.
    Je, Y.
    Kaymakcalan, M. D.
    Sonpavde, G.
    Choueiri, T. K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (02) : 296 - 305
  • [35] Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor
    Gallicchio, M
    Mitola, S
    Valdembri, D
    Fantozzi, R
    Varnum, B
    Avanzi, GC
    Bussolino, F
    BLOOD, 2005, 105 (05) : 1970 - 1976
  • [36] Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Ghatalia, Pooja
    Morgan, Charity J.
    Je, Youjin
    Nguyen, Paul L.
    Quoc-Dien Trinh
    Choueiri, Toni K.
    Sonpavde, Guru
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (02) : 228 - 237
  • [37] Tyrosine kinase expression profile in clear cell renal cell carcinoma
    Behbahani, Turang E.
    Thierse, Claudia
    Baumann, Claudia
    Holl, Daniel
    Bastian, Patrick J.
    von Ruecker, Alexander
    Mueller, Stefan C.
    Ellinger, Joerg
    Hauser, Stefan
    WORLD JOURNAL OF UROLOGY, 2012, 30 (04) : 559 - 565
  • [38] Tyrosine kinase expression profile in clear cell renal cell carcinoma
    Turang E. Behbahani
    Claudia Thierse
    Claudia Baumann
    Daniel Holl
    Patrick J. Bastian
    Alexander von Ruecker
    Stefan C. Müller
    Jörg Ellinger
    Stefan Hauser
    World Journal of Urology, 2012, 30 : 559 - 565
  • [39] Efficacy of adjuvant vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (VEGFRi) in renal cell carcinoma (RCC): A systematic review and meta-analysis
    Ayer Botrel, Tobias Engel
    Clark, Otavio
    Horta Bretas, Francisco Flavio
    Sadi, Marcus V.
    Ferreira, Ubirajara
    Paladini, Luciano
    Matheus, Wagner
    Duraes, Ronilson Oliveira
    Lima Pompeu, Antonio Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [40] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer
    Xu, Jianlin
    Chu, Tianqing
    Jin, Bo
    Dong, Xue
    Lou, Yuqing
    Zhang, Xueyan
    Wang, Huiming
    Zhong, Hua
    Shi, Chunlei
    Gu, Aiqing
    Xiong, Liwen
    Zhao, Yizhuo
    Jiang, Liyan
    Zhang, Jie
    Han, Baohui
    CLINICAL LUNG CANCER, 2016, 17 (04) : 309 - 314